Article
Therapy resistance in neuroblastoma: Mechanisms and reversal strategies
16 Feb 2023
Abstract excerpt
Neuroblastoma is one of the most common pediatric solid tumors that threaten the health of children, accounting for about 15% of childhood cancer-related mortality in the United States. Currently, multiple therapies have been developed and applied in clinic to treat neuroblastoma including chemotherapy, radiotherapy, targeted therapy, and immunotherapy. However, the resistance to therapies is inevitable following...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.